Blood cell DNA marks linked to differences in gene activity
Researchers identified 599 regions where the two copies of DNA in blood cells from one Asian individual carried different chemical marks. These differences were strongly correlated with differences in gene activity. Published in PLoS Biol on 9 November 2010, the study by Li Y and colleagues reported a 92.62% complete map of DNA methylation. It examined peripheral blood mononuclear cells, or PBMCs, an important source for clinical blood tests.
DNA methylation is the presence of chemical marks on DNA; a methylome is a map of those marks across the genome. The researchers used whole-genome bisulfite sequencing to read the marks, with 24.7-fold coverage overall and 12.3-fold per strand. Coverage describes how many times the DNA was read. The participant's genome had already been sequenced in the YH project, allowing the team to compare the methylation map with the same person's DNA sequence.
At CpG sites, where a cytosine DNA letter precedes a guanine, 68.4% were methylated. Less than 0.2% of non-CpG sites carried the marks. The authors concluded that methylation outside CpG sites was minor in these cells. They also examined methylation across 20 distinct genomic features, including regulatory, protein-coding, non-coding, RNA-coding and repeated sequences.
The 599 regions with different methylation between genome copies covered 287 genes. Of these, 76 genes had such regions within 2 kb of their transcriptional start sites, the points where the process of reading a gene begins. A kb represents 1,000 DNA base pairs, the paired letters that make up the DNA sequence. Among those genes, more than 80% displayed allele-specific expression, meaning that their two copies differed in activity. The authors found that differences in methylation between copies were recurrent and strongly correlated with these differences in expression in human PBMCs.
Combining the methylation map with the YH genome sequence enabled what the authors described as the first comprehensive assessment of allele-specific methylation between an individual's two genome copies. It also provided a resource for future epigenomic research, which examines chemical marks across the genome. Together with similar studies, the authors said, the work confirmed sequencing technology as an approach for large-scale epigenomics studies.